SNT
ATRS

Security National Trust’s Antares Pharma, Inc. ATRS Stock Holding History

Security National Trust’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,454
Closed -$6K – 426
2020
Q4 		$6K Buy
+1,454
New +$4.7K ﹤0.01% 377

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Security National Trust's ATRS Position: Q1 2021 in Review

Security National Trust sold out of Antares Pharma, Inc. (ATRS) in Q1 2021, closing a stake of 1,454 shares — an estimated $6K sold.

Security National Trust first reported a position in ATRS in Q4 2020 and held it in 1 quarter. The position peaked at $6K in Q4 2020. 171 funds tracked by Wall St. Rank hold ATRS as of Q1 2021.

  • Security National Trust reported no remaining Antares Pharma, Inc. position as of Q1 2021 after selling out during the quarter.
  • Security National Trust sold 1,454 Antares Pharma, Inc. shares in Q1 2021, an estimated $6K.
  • Security National Trust first reported a position in Antares Pharma, Inc. in Q4 2020 and held it in 1 quarter.
  • Security National Trust's Antares Pharma, Inc. position peaked at $6K in Q4 2020.
  • 171 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2021.

Based on Security National Trust's 13F filing for Q1 2021, filed 4 May 2021.